Login/Register

News

PBF expects approval of its nephrology drug Nephoxil in China by 2023

The Company explained that in accordance with the requirements by the Chinese government, chemical APIs are required to apply for the registration along with relevant research data.

Read more
Jul 06, 2023
Liberty Times
Jul 05, 2023
Economic Daily
Jul 04, 2023
Investor.com.tw
Jul 03, 2023
Bora Pharmaceuticals
Jun 30, 2023
Tssdnews.com.tw
Jun 29, 2023
Pharmosa Biopharm
Jun 28, 2023
Cnyes.com
Jun 27, 2023
Cnyes.com
Jun 26, 2023
Taipei Times